Literature DB >> 15185869

Renal insufficiency may partly explain chronic anemia in patients awaiting liver transplantation.

Cary H Patt1, Kyrsten D Fairbanks, Paul J Thuluvath.   

Abstract

In patients with cirrhosis, anemia is common and is likely to be multifactorial, including decreased erythrocyte production, sequestration due to hypersplenism, hemolysis, and increased blood loss from gastrointestinal bleeding. Renal dysfunction is also common in liver disease and this may also cause anemia. However, an association between anemia and renal dysfunction has not been reported in patients with cirrhosis. Our objective was to determine whether anemia in cirrhotic patients is independently related to renal dysfunction. We conducted a retrospective chart review of patients in our institution listed for liver transplantation. We collected simultaneous data on age, hemoglobin, creatinine, albumin, liver enzymes, prothrombin time, and bilirubin. We excluded patients who were hospitalized or deceased to avoid confounding variables. Two hundred eighty-six (female n = 130) patients with a mean age of 52.8 +/- 9.7 (range, 18-73) years were studied. Renal dysfunction (creatinine > 1.2 mg/dL) was present in 55 (19%) patients, and anemia (hemoglobin < 12 g/dL) was seen in 115 (40%) patients. Anemia was more common in patients with renal dysfunction (64 versus 34%; P < 0.001) compared to those with normal renal function. Creatinine, prothrombin time, and bilirubin showed an inverse relationship (all P's < 0.001) with hemoglobin, and albumin showed a positive correlation with hemoglobin (P < 0.001). Multivariate analysis showed that creatinine (OR, 2.4; 95% CI, 1.05-5.3; P = 0.038), prothrombin time (P = 0.026), bilirubin (P = 0.035), and albumin (P = 0.001) were independent predictors of anemia. Renal dysfunction is an important cause of anemia in patients with cirrhosis. The role of erythropoietin in the management of anemia in patients with cirrhosis and renal dysfunction should be explored in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185869     DOI: 10.1023/b:ddas.0000026309.48324.ba

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  Erythropoietin.

Authors:  A J Erslev
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Erythropoietin response to post-liver transplantation anemia.

Authors:  S Vasilopoulos; R Hally; J Caro; P Martin; S Westerberg; M Moritz; B Jarrell; S Muñoz
Journal:  Liver Transpl       Date:  2000-05       Impact factor: 5.799

3.  Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.

Authors:  I Cirera; J I Elizalde; J M Piqué; F Feu; M Casadevall; E Goldin; J Terés; J Bosch; J Rodés
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

4.  Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.

Authors:  J S Kaufman; D J Reda; C L Fye; D S Goldfarb; W G Henderson; J G Kleinman; C A Vaamonde
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

5.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

Authors:  J D Harnett; R N Foley; G M Kent; P E Barre; D Murray; P S Parfrey
Journal:  Kidney Int       Date:  1995-03       Impact factor: 10.612

6.  Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy.

Authors:  V Wizemann; R Schäfer; W Kramer
Journal:  Nephron       Date:  1993       Impact factor: 2.847

7.  Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia.

Authors:  M Siciliano; D Tomasello; A Milani; B M Ricerca; S Storti; L Rossi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

8.  A study on the mechanism of anemia and leukopenia in liver cirrhosis.

Authors:  I Ohki; K Dan; S Kuriya; T Nomura
Journal:  Jpn J Med       Date:  1988-05

9.  Anemia increases gastric blood flow in noncirrhotic and cirrhotic patients.

Authors:  I Cirera; J Panés; J M Bordas; J Llach; J Bosch; J M Piqué; J Terés; J Rodés
Journal:  Gastrointest Endosc       Date:  1995-11       Impact factor: 9.427

10.  Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.

Authors:  J Pascual; J L Teruel; J L Moya; F Liaño; M Jiménez-Mena; J Ortuño
Journal:  Clin Nephrol       Date:  1991-06       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.